J. Vičar
Impact in
-
- Berberine and alkaloids research
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Chemical Synthesis and Analysis 8
- DNA and Nucleic Acid Chemistry 4
- Oncology 11
- Peptidase Inhibition and Analysis 8
- Co-authors
- K. Bláha (11 shared papers)E Kr̆epela (7 shared papers)Miloš Buděšı́nský (2 shared papers)Jitka Ulrichová (7 shared papers)Vilı́m Šimánek (6 shared papers)P. Fromageot (4 shared papers)Serge Fermandjian (4 shared papers)I. Frič (4 shared papers)
In The Last Decade
J. Vičar
29 papers receiving 423 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 81
- Cancer Research 61
- Spectroscopy 62
- Molecular Biology 231
- Organic Chemistry 99
Countries citing papers authored by J. Vičar
This map shows the geographic impact of J. Vičar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Vičar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Vičar more than expected).
Fields of papers citing papers by J. Vičar
This network shows the impact of papers produced by J. Vičar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Vičar. The network helps show where J. Vičar may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Vičar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 50 | |
| 2 | 1973 | 41 | |
| 3 | 1987 | 36 | |
| 4 | 1975 | 32 | |
| 5 | 2007 | 32 | |
| 6 | Cathepsin B in human breast tumor tissue and cancer cells. | 1989 | 26 |
| 7 | 2003 | 25 | |
| 8 | 1976 | 25 | |
| 9 | 1979 | 24 | |
| 10 | 1973 | 22 | |
| 11 | 1972 | 17 | |
| 12 | 1972 | 16 | |
| 13 | Quaternary benzo[c]phenanthridine alkaloids as inhibitors of dipeptidyl peptidase IV-like activity baring enzymes in human blood plasma and glioma cell lines. | 2003 | 15 |
| 14 | Demonstration of two molecular forms of dipeptidyl peptidase IV in normal human serum. | 1983 | 13 |
| 15 | 2003 | 12 | |
| 16 | 1973 | 12 | |
| 17 | An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-L-proline-1-naphthylamide and other glycyl-L-proline-arylamides as substrates. | 1983 | 10 |
| 18 | 1977 | 9 | |
| 19 | 1977 | 8 | |
| 20 | 1979 | 7 |
About J. Vičar
J. Vičar is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cancer Research and Pharmacology, having authored 30 papers that have together received 463 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (8 papers), Peptidase Inhibition and Analysis (8 papers), Protease and Inhibitor Mechanisms (6 papers), Berberine and alkaloids research (5 papers), Bone and Dental Protein Studies (4 papers), DNA and Nucleic Acid Chemistry (4 papers), Synthesis of β-Lactam Compounds (3 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Pharmacology (81 citations), Cancer Research (61 citations), Spectroscopy (62 citations), Molecular Biology (231 citations) and Organic Chemistry (99 citations). J. Vičar has collaborated with scholars based in Czechia, Russia and France. Frequent co-authors include K. Bláha, E Kr̆epela, Miloš Buděšı́nský, Jitka Ulrichová, Vilı́m Šimánek, P. Fromageot, Serge Fermandjian, I. Frič, Aleksi Šedo and David Rasnick. Their work appears in journals such as Xenobiotica, Physiological Research, Tetrahedron Letters, Proceedings of the National Academy of Sciences and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.